(May 22, 2018, 11:01 AM EDT) -- SILVER SPRING, Md. — The Food and Drug Administration on May 18 issued a drug safety communication that the HIV drug dolutegravir, sold as Tivicay, Juluca and Trimeq, has been associated with neural tube birth defects in an African observational study....